Clinical Trials

Rheumatoid Arthritis Drug Development Solutions

There remains a significant unmet need in the treatment of rheumatoid arthritis (RA): there is no cure, treatments are often inconvenient and expensive, and safety is still a concern. Covance understands the challenges faced in RA clinical development, and has the insight and experience to help you achieve success.

Understanding rheumatoid arthritis industry demands

A trend towards more aggressive treatment under the 'treat to target' strategy

Steady market growth due in part to aging population

Movement towards early diagnosis and treatment of patients

Expanded range of treatment options including novel biologics and small molecules

Increasing availability of biosimilars making biologic treatments more accessible

The nature of RA trials and the current development landscape cause a number of challenges in many RA clinical development programs. Covance has developed solutions to overcome each of these and help you along the path to success.

Through our extensive experience in RA clinical trials we have accrued the operational and scientific expertise, along with the necessary infrastructure, to help you meet timelines and save costs in your RA clinical development program.